Mark G. Currie

20.8k citations

219 papers · 17.0k indexed · 8 hit papers · h-index 63

Impact in

Gastroenterology top 0.05%
- Gastrointestinal motility and disorders
Biochemistry top 0.1%
- Eicosanoids and Hypertension Pharmacology

Papers in

Gastroenterology 61
- Gastrointestinal motility and disorders 55
- Gastroesophageal reflux and treatments 22
Biochemistry 24
- Eicosanoids and Hypertension Pharmacology 21

Co-authors: Thomas P. Misko Philip Needleman Pamela T. Manning Daniela Salvemini Karen Seibert Jaime L. Masferrer David M. Geller William M. Moore
Journals: Gastroenterology (36 papers)The American Journal of Gastroenterology (13 papers)Biochemical and Biophysical Research Communications (12 papers)Proceedings of the National Academy of Sciences (9 papers)Journal of Medicinal Chemistry (8 papers)
Partner nations: United States Japan Canada

In The Last Decade

Mark G. Currie

212 papers receiving 16.3k citations

Hit Papers

8 papers align trajectories log scale

Linaclotide for Irritable Bowel Syndrome With Constipation: A 26-Week, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate Efficacy and Safety 2012 · 340 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2012 The American Journal of Gastroenterology
1996 British Journal of Pharmacology
1993 Analytical Biochemistry
1993 European Journal of Pharmacology
1993 Proceedings of the National Academy of Sciences
1992 Proceedings of the National Academy of Sciences
1984 Science
1983 Science

Peers

Countries citing papers authored by Mark G. Currie

Since Specialization

Citations

This map shows the geographic impact of Mark G. Currie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark G. Currie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark G. Currie more than expected).

Fields of papers citing papers by Mark G. Currie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark G. Currie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark G. Currie. The network helps show where Mark G. Currie may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark G. Currie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark G. Currie Line = papers co-authored together Mark G. Currie links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Effect of Praliciguat, a Once-Daily, Oral Soluble Guanylate Cyclase Stimulator, on Albuminuria in Patients with Diabetic Kidney Disease: A Randomized, Double-Blind, Phase 2 Trial Journal of the American Society of Nephrology ·John P. Hanrahan, Ian H. de Boer, George L. Bakris, Phebe Wilson, James Wakefield, Jelena P. Seferović, Jennifer Chickering, Michael D. Cressman, Mark G. Currie, G. Todd Milne, Albert T. Profy	2020	1
2	Linaclotide in irritable bowel syndrome with constipation: A Phase 3 randomized trial in China and other regions Journal of Gastroenterology and Hepatology ·Yunsheng Yang, (unknown), Jing‐Yuan Fang, Xiaozhong Guo, Ning Dai, Xizhong Shen, Youlin Yang, Jing Sun, Bal Raj Bhandari, David S. Reasner, Jacquelyn A. Cronin, Mark G. Currie, Jeffrey M. Johnston, Peter YF. Zeng, N Montreewasuwat, George Zhijian Chen, Sam Lim	2018	39
3	Multiple-Ascending-Dose Study of the Soluble Guanylate Cyclase Stimulator, IW-1701, in Healthy Subjects Blood ·Robert S. Mittleman, Phebe Wilson, Kristine Sykes, Marina Mihova, Jennifer Chickering, Dennis Ruff, Michael Hall, Todd Milne, Mark G. Currie, Yueh‐tyng Chien	2017	5
4	The Clinical-Stage sGC Stimulator IW-1701 Prevents Increase of Plasma Biomarkers of Intravascular Inflammation and Suppresses Leukocyte-Endothelial Interactions in Tnfα-Treated Mice Blood ·Boris Tchernychev, Susanne Feil, Peter Germano, William P. Warren, Elisabeth Lonie, Robert Feil, Todd Milne, John R. Hadcock, Yueh‐tyng Chien, Mark G. Currie, Regina Margaret Graul	2017	4
5	MRP4 Modulation of the Guanylate Cyclase-C/cGMP Pathway: Effects on Linaclotide-Induced Electrolyte Secretion and cGMP Efflux Journal of Pharmacology and Experimental Therapeutics ·Boris Tchernychev, Pei Ge, Marco M. Kessler, Robert Solinga, Derek Wachtel, Jenny Tobin, Sara R. Thomas, Craig E. Lunte, Angelika Fretzen, Gerhard Hannig, Alexander P. Bryant, Caroline B. Kurtz, Mark G. Currie, Inmaculada Silos‐Santiago	2015	22
6	PWE-166 Is Response To Linaclotide After 4 Weeks Of Treatment Predictive Of 12-week Improvement? Gut ·William D. Chey, Bernard J. Lavins, Steven J. Shiff, James E. MacDougall, Caroline B. Kurtz, Mark G. Currie, JM Johnston	2014	0
7	Linaclotide Inhibits Colonic Nociceptors and Relieves Abdominal Pain via Guanylate Cyclase-C and Extracellular Cyclic Guanosine 3′,5′-Monophosphate Gastroenterology ·Joel Castro, Andrea M. Harrington, Patrick A. Hughes, Christopher M. Martin, Pei Ge, Courtney Shea, Hong Jin, Sarah Jacobson, Gerhard Hannig, Elizabeth A. Mann, Mitchell B. Cohen, James E. MacDougall, Bernard J. Lavins, Caroline B. Kurtz, Inmaculada Silos‐Santiago, Jeffrey M. Johnston, Mark G. Currie, L. Ashley Blackshaw, Stuart M. Brierley	2013	228
8	Randomised clinical trials: linaclotide phase 3 studies in IBS ‐C – a prespecified further analysis based on European Medicines Agency‐specified endpoints Alimentary Pharmacology & Therapeutics ·Eamonn M.M. Quigley, Jan Tack, William D. Chey, Supriya Rao, J Fortea, M. Falqués, C Díaz, Steven J. Shiff, Mark G. Currie, Jeffrey M. Johnston	2012	92
9	A 12-Week, Randomized, Controlled Trial With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Linaclotide in Irritable Bowel Syndrome With Constipation The American Journal of Gastroenterology ·Satish S.C. Rao, Anthony Lembo, Steven J. Shiff, Bernard J. Lavins, Mark G. Currie, Xinwei D. Jia, Kelvin Shi, James E. MacDougall, James Shao, Paul Eng, Susan M. Fox, Harvey Schneier, Caroline B. Kurtz, Jeffrey M. Johnston	2012	293
10	Linaclotide for Irritable Bowel Syndrome With Constipation: A 26-Week, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate Efficacy and Safety The American Journal of Gastroenterology ·William D. Chey, Anthony Lembo, Bernard J. Lavins, Steven J. Shiff, Caroline B. Kurtz, Mark G. Currie, James E. MacDougall, Xinwei D. Jia, James Shao, Donald A. Fitch, Mollie Baird, Harvey Schneier, Jeffrey M. Johnston Hit paper breakdown →	2012	340
11	In vitro and in vivo evaluation of O-alkyl derivatives of tramadol Bioorganic & Medicinal Chemistry Letters ·Liming Shao, Michael C. Hewitt, Thomas P. Jerussi, Frank Wu, Scott C. Malcolm, Paul Grover, Kevin Fang, Patrick Koch, Chris H. Senanayake, Nandkumar N. Bhongle, Seth Ribe, Roger P. Bakale, Mark G. Currie	2008	8
12	A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats David P. Rotella, Zhou-Zheng Wang, J. L. Zweier, Alexandre Samouilov, Heather Macarthur, Thomas P. Misko, Mark G. Currie, Salvatore Cuzzocrea, James A. Sikorski, Dennis P. Riley	2000	17
13	Protective effects of a superoxide dismutase mimetic and peroxynitrite decomposition catalysts in endotoxin‐induced intestinal damage British Journal of Pharmacology ·Daniela Salvemini, Dennis P. Riley, Patrick J. Lennon, Zhiqiang Wang, Mark G. Currie, Heather Macarthur, Thomas P. Misko	1999	117
14	A new short practical quality of life questionnaire for use in Head and Neck Oncology outpatient clinics Clinical Otolaryngology ·Patrick Young, Nigel Beasley, David Houghton, David Husband, Mark G. Currie, B. CHISLETT, A. S. Jones	1998	8
15	Temporal relationships of cytokine production in mouse non-lethal sepsis: Effect of nitric oxide synthase inhibitors Inflammation Research ·D. J. Fretland, C. P. Anglin, D. L. Widomski, Jane R. Connor, Pamela S. Wyatt, Pamela T. Manning, Mark G. Currie	1997	5
16	Prouroguanylin and proguanylin: purification from colon, structure, and modulation of bioactivity by proteases. Endocrinology ·F. K. Hamra, Xin Fan, W. Kŕause, Ronald H. Freeman, David T. Chin, Christine E. Smith, Mark G. Currie, Leonard R. Forte	1996	68
17	L-N6-(1-Iminoethyl)lysine: A Selective Inhibitor of Inducible Nitric Oxide Synthase Journal of Medicinal Chemistry ·William M. Moore, R. Keith Webber, Gina Jerome, Foe S. Tjoeng, Thomas P. Misko, Mark G. Currie	1994	394
18	Glucocorticoid Regulation of Atrial Natriuretic Peptide Receptors on Cultured Endothelial Cells* Endocrinology ·Katherine L. Lanier-Smith, Mark G. Currie	1991	21
19	Effect of glucocorticoids on the binding of atrial natriuretic peptide to endothelial cells European Journal of Pharmacology ·Katherine L. Lanier-Smith, Mark G. Currie	1990	14
20	Regulation of atriopeptin release from the isolated rat heart Fed. Proc., Fed. Am. Soc. Exp. Biol.; (United States) ·Mark G. Currie, Walter H. Newman	1986	0

About Mark G. Currie

Mark G. Currie is a scholar working on Gastroenterology, Biochemistry, Physiology, Endocrinology and Endocrinology, Diabetes and Metabolism, having authored 219 papers that have together received 17.0k indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (58 papers), Gastrointestinal motility and disorders (55 papers), Gastroesophageal reflux and treatments (22 papers), Eicosanoids and Hypertension Pharmacology (21 papers), Helicobacter pylori-related gastroenterology studies (20 papers), Congenital gastrointestinal and neural anomalies (18 papers), Receptor Mechanisms and Signaling (17 papers) and Intestinal Malrotation and Obstruction Disorders (15 papers). The work is most often cited by research in Gastroenterology (2.8k citations), Biochemistry (1.6k citations), Physiology (5.2k citations), Cardiology and Cardiovascular Medicine (2.6k citations) and Pharmacology (1.7k citations). Mark G. Currie has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include Thomas P. Misko, Philip Needleman, Pamela T. Manning, Daniela Salvemini, Karen Seibert, Jaime L. Masferrer, David M. Geller, Daniela Salvemini, William M. Moore and Caroline B. Kurtz. Their work appears in journals such as Gastroenterology, The American Journal of Gastroenterology, Biochemical and Biophysical Research Communications, Proceedings of the National Academy of Sciences and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact